Ftse Mib
34.239,49
-0,40%
DAX
18.479,49
-0,65%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,00%
Bitcoin
63.689,76
-1,79%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Motif Bio Plc (MTFB) Motif Bio Plc (MTFB) Notizie

MTFB

Motif Bio (MTFB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB
DataOraFonteTitoloSimboloCompagnia
02/02/201816:57Alliance NewsAlliance NewsMotif Bio Chief Financial Officer Robert Dickey To ResignLSE:MTFBMotif Bio Plc
02/02/201816:00UK RegulatoryMotif Bio PLC Appointment of Interim Chief Financial OfficerLSE:MTFBMotif Bio Plc
29/01/201816:17PR Newswire (US)Motif Bio PLC, Spero Therapeutics, Inc. and Vical Incorporated Join Antimicrobials Working GroupLSE:MTFBMotif Bio Plc
29/01/201813:07UK RegulatoryMotif Bio PLC Second Price Monitoring ExtnLSE:MTFBMotif Bio Plc
29/01/201813:02UK RegulatoryMotif Bio PLC Price Monitoring ExtensionLSE:MTFBMotif Bio Plc
19/01/201808:00UK RegulatoryMotif Bio PLC Filing of U.S. Shelf RegistrationLSE:MTFBMotif Bio Plc
16/01/201814:11Alliance NewsAlliance NewsMotif Bio Secures Funding To Advance Iclaprim DevelopmentLSE:MTFBMotif Bio Plc
16/01/201808:00UK RegulatoryMotif Bio PLC Motif Bio Receives Award from CF FoundationLSE:MTFBMotif Bio Plc
12/01/201816:12UK RegulatoryMotif Bio PLC Holding(s) in CompanyLSE:MTFBMotif Bio Plc
08/01/201816:51Alliance NewsAlliance NewsMotif Bio Issues 471,602 Shares Following Warrants Exercise (ALLISS)LSE:MTFBMotif Bio Plc
08/01/201816:23UK RegulatoryMotif Bio PLC Exercise of WarrantsLSE:MTFBMotif Bio Plc
05/01/201808:00RNS Non-RegulatoryMotif Bio PLC Motif Bio to participate in panel discussionLSE:MTFBMotif Bio Plc
22/12/201708:01UK RegulatoryMotif Bio PLC Notes statement from Amphion InnovationsLSE:MTFBMotif Bio Plc
21/12/201714:29Alliance NewsAlliance NewsMotif Bio Says Additional Iclaprim Study Results Published In JournalLSE:MTFBMotif Bio Plc
21/12/201714:00RNS Non-RegulatoryMotif Bio PLC REVIVE-1 additional results publishedLSE:MTFBMotif Bio Plc
14/12/201708:01RNS Non-RegulatoryMotif Bio PLC Filing of SEC Form F-3LSE:MTFBMotif Bio Plc
17/11/201711:08Alliance NewsAlliance NewsMotif Bio Gets GBP59,000 From Warrant Exercise (ALLISS)LSE:MTFBMotif Bio Plc
17/11/201708:20Alliance NewsAlliance News*Motif Bio To Issue 183,031 Shares For GBP58,935 From Warrants Exercise (ALLISS)LSE:MTFBMotif Bio Plc
15/11/201710:46Alliance NewsAlliance NewsMotif Bio Secures USD20 Million Debt Facility From Hercules CapitalLSE:MTFBMotif Bio Plc
15/11/201708:00UK RegulatoryMotif Bio PLC Secures up to US$20 million debt financingLSE:MTFBMotif Bio Plc
06/11/201714:07Alliance NewsAlliance NewsBank Of America Raises Stake In Biopharmaceutical Firm Motif Bio (ALLISS)LSE:MTFBMotif Bio Plc
06/10/201715:19Alliance NewsAlliance NewsMerrill Lynch Ups Motif Bio Stake Following Iclaprim Results (ALLISS)LSE:MTFBMotif Bio Plc
06/10/201710:54Alliance NewsAlliance NewsMotif Bio Receives Positive Pre-Clinical Data For Iclaprim DrugLSE:MTFBMotif Bio Plc
06/10/201708:00RNS Non-RegulatoryMotif Bio PLC New Pre-Clinical Data for Iclaprim at IDWeek 2017LSE:MTFBMotif Bio Plc
04/10/201709:31Alliance NewsAlliance NewsMotif Bio Shares Jump On Positive Late-Stage Iclaprim Study ResultsLSE:MTFBMotif Bio Plc
04/10/201708:00UK RegulatoryMotif Bio PLC Positive Topline Results in Phase Three StudyLSE:MTFBMotif Bio Plc
29/09/201713:22Alliance NewsAlliance NewsMotif Bio On Track For Strategic Goals As Interim Loss WidensLSE:MTFBMotif Bio Plc
29/09/201708:02UK RegulatoryMotif Bio PLC Half-year ReportLSE:MTFBMotif Bio Plc
25/09/201711:42Alliance NewsAlliance NewsAmphion Innovations Sells 4.4 Million Shares In Motif Bio In Loan Deal (ALLISS)LSE:MTFBMotif Bio Plc
15/09/201715:21Alliance NewsAlliance NewsMotif Bio's Iclaprim Gets Orphan Drug Status For Lung InfectionsLSE:MTFBMotif Bio Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
FBK
Finecobank
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
BC
Brunello Cucinelli
BIT
PRY
Prysmian
BIT
SPM
Saipem
BIT
G
Generali
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network